Veteran strategist Jim Paulsen predicts the typical November-to-April stock market rally may fail this year due to tightening financial conditions, according to MarketWatch.
After the Fed raised rates to 3.75%-4%, Jim Cramer says buying stocks now is effectively fighting the Fed, signaling a tightening path that could weigh on equities; the stock universe to buy is shrinking, investors may seek defensives like pharma, and higher 10-year yields offer a risk-free alternative as inflation eases.
New Zealand’s Guardians of NZ Superannuation, which manages about NZ$54 billion, warned U.S. equities could cool after a long run even as the fund posted a 14.2% return to June 30 and grew to NZ$94.4 billion. The fund, ranked the world’s top-performing SWF earlier this year, also lowered its long-term equity return projection to 7.2% and reduced its active risk, emphasizing a diversified portfolio. Top holdings include Nvidia, Apple, Microsoft, Alphabet and Amazon, with the U.S. equity sleeve worth about NZ$31.7 billion. The fund, established in 2001 to ease future pension costs, expects its first withdrawals in 2054.
The 2026 U.S. midterms are a backdrop for markets, with history showing midterm years can be weaker but often followed by a rally as uncertainty fades. Sector performance varies, with healthcare and energy historically more resilient, while financials lag at times. The AI boom remains a key theme, supporting AI-focused and broad-market ETFs (e.g., CHAT, VOO, SPYM, RSP), and investors are advised to stay invested rather than react to political outcomes, as relief rallies typically occur after elections and strength can persist into year-end.
Investors are eyeing August's inflation report, with probability of a September Fed rate hike remaining elevated, shaping near-term moves in U.S. equities and broader market expectations.
A busy week looms for markets with the release of PCE inflation data, Nvidia earnings, and the Federal Reserve’s Jackson Hole symposium, as investors parse inflation signals, tech results, and policy guidance.
JPMorgan raised its 2026 end-of-year S&P 500 target to 8,000 from 7,800, citing stronger corporate earnings and early signs that AI-related spending is translating into growth. The bank also boosted its 2026 EPS forecast to $365 (about 35% annual growth) and its 2027 projection to $420, while keeping a roughly 20x forward earnings multiple amid higher rates and risks. AI infrastructure spending remains the central driver, with AI capex estimated near $900 billion this year and over $1.2 trillion next year, supported by cloud trends at Microsoft, Amazon, and Alphabet, though higher investment weighs on free cash flow.
Wall Street is expected to have a relatively calm earnings season, with negative earnings preannouncements well below typical levels and consensus estimates on the rise. JPMorgan strategist Mislav Matejka says rising estimates reflect genuine improvements in corporate fundamentals rather than analyst complacency. The S&P 500 is seen posting about 23.3% year-over-year Q2 earnings growth, above the five-year (16.4%) and 10-year (10.3%) averages. Ten of 11 sectors are expected to grow, led by Energy, Technology and Materials, with big hyperscalers’ capex boosting hardware and data-center spending. Despite inflation and geopolitics, consumer resilience has helped keep the broader U.S. economy stable.
CNBC host Jim Cramer calls the elevated CPI readings 'artificial inflation' and outlines what the development could mean for stock prices and market expectations.
JPMorgan argues that with market volatility, investors should consider unloved but dividend‑paying stocks for defensive income and downside protection, favoring safer, income-generating equities over high‑fliers.
Nvidia stock is hovering near a crucial price level that could determine its near-term direction, with traders watching for a breakout or reversal as they gauge the next move.
As SpaceX prepares its blockbuster IPO, the piece argues that an overlooked industrial stock could reap significant benefits, presenting a compelling investing angle amid the IPO excitement.
Investors are nervous ahead of the Fed decision and major earnings. Rev Shark has raised cash to about 45% and will wait for tonight’s results before new moves, having added BridgeBio Pharma after a patent-litigation resolution and eyeing SoFi Technologies after an earnings-driven selloff, while noting SoFi’s tech platform revenue fell 27% year over year. He remains long Alphabet (GOOGL) and BBIO, expecting earnings and energy-cost inflation signals to drive the next market moves.
Goldman Sachs expects global merger-and-acquisition volume to reach about $3.8 trillion, driven by AI-enabled long-term value strategies and private-equity asset sales. Large deals (> $10B) have already risen, signaling broader activity into 2026, with the cycle described as mid-stage and likely to persist despite ongoing uncertainty. GS is rated a Moderate Buy by analysts, with a potential upside around mid-single digits.
The S&P 500 hovers near 7,000 thanks to hedged positioning, CTA flows, liquidity tailwinds, and AI trade momentum, but the author expects meaningful downside in the next 2–3 months due to geopolitical risks, persistent inflation, and adverse seasonality. Current VIX levels offer a hedging window with put spreads targeting a 5–10% pullback and a potential VIX spike, while maintaining AI and Mag 7 exposures but employing tactical hedges amid earnings risk and macro volatility.